Amryt says integration of acquired company Aegerion ‘progressing well’
Dublin-based biopharma company has cash position of $60.9m
Amryt acquires company with plans to grow portfolio
Group plots dual Nasdaq listing to create enlarged rare disease company
Amryt signs new deal to expand Lojuxta licence
Firms estimates new deal will increase number of patients for treatment by 25%
YOU MAY ALSO LIKE...
Crosswords & Puzzles
Crosswords & puzzles to keep you challenged and entertained
Six Nations 2025
Get the latest news, analysis and match reports from the M6N and W6N championships
Common Ground
How does a post-Brexit world shape the identity and relationship of these islands
Family NoticesOpens in new window
Weddings, Births, Deaths and other family notices